Stock analysis searches answered, part 41 of 43

Black diamond therapeutics black diamond therapeutics

Also searched as: "black diamond therapeutics" | "black diamond therapeutics"

For “Black diamond therapeutics black diamond therapeutics”, the matching SEC registrant is Black Diamond Therapeutics, Inc., which trades as BDTX and files under Central Index Key 1701541. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was Aset Therapeutics, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-21, across 485 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-16 by Black Diamond Therapeutics, Inc. (CIK 1701541) — source document:

We are a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of our company is built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Our MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type mediated toxicities, and be brain-penetrant to treat central nervous system (CNS) disease. Our compounds target families of oncogenic mutations in clinically validated pathways. Our lead clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC).

Financial trend for Black Diamond Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$91.17 million (2022-12-31) to $22.37 million (2025-12-31), a change of +124.5%; total assets went from $156.25 million (2022-12-31) to $143.01 million (2025-12-31), a change of -8.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1701541, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Black Diamond Therapeutics, Inc. did not tag for that period.

Black Diamond Therapeutics, Inc. has 485 filings in its recent EDGAR index, including 7 annual reports and 20 quarterly reports; its newest filing is a 4 from 2026-09-21.

Current reports. Of the 61 8-K or 6-K reports in Black Diamond Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-08-05, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1701541 is on the EDGAR company page; the latest 10-K there is dated 2026-03-16 and the oldest filing in the recent index dates from 2017-03-28. Insider trades for Black Diamond Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Bluejay diagnostics bluejay diagnostics inc. bluejaydx.com bluejaydx bjdx

Also searched as: "bluejay diagnostics" | "bluejay diagnostics inc." | "bluejaydx.com" | "bluejaydx" | "bjdx"

For “Bluejay diagnostics bluejay diagnostics inc. bluejaydx.com bluejaydx bjdx”, the matching SEC registrant is Bluejay Diagnostics, Inc., which trades as BJDX and files under Central Index Key 1704287. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-13, across 248 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-06 by Bluejay Diagnostics, Inc. (CIK 1704287) — source document:

Bluejay Diagnostics, Inc. (“Bluejay”) is a medical diagnostics company focused on improving patient outcomes in critical care settings, with a focus on sepsis. We are working on developing rapid, near-patient tests using whole blood on our Symphony technology platform (“Symphony”), which consists of an analyzer and single-use protein detection cartridges. We do not yet have regulatory clearance for Symphony, and we will need to receive regulatory authorization from the U.S. Food and Drug Administration (the “FDA”) before Symphony can be marketed as a diagnostic product in the United States. We have completed the pre-clinical development of the Symphony analyzer. During 2026, we transferred the knowledge, technology and process underlying the production of the Symphony cartridges from the original developer and outside supplier, Toray Industries, to a contract manufacturing facility with FDA certification run by Sanyoseiko.

Financial trend for Bluejay Diagnostics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue was tagged only for 2022-12-31 at $249,040; net income (loss) went from -$9.30 million (2022-12-31) to -$6.85 million (2025-12-31), a change of +26.3%; total assets went from $13.52 million (2022-12-31) to $7.12 million (2025-12-31), a change of -47.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1704287, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Bluejay Diagnostics, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Bluejay Diagnostics, Inc. (CIK 1704287) lists its business address as 360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA, which helps confirm you are on the right company’s site.

Current reports. Of the 67 8-K or 6-K reports in Bluejay Diagnostics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-13 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1704287 is on the EDGAR company page; the latest 10-K there is dated 2026-03-06 and the oldest filing in the recent index dates from 2017-04-19. Insider trades for Bluejay Diagnostics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Briacell therapeutics briacell therapeutics corp briacell.com

Also searched as: "briacell therapeutics" | "briacell therapeutics corp" | "briacell.com"

For “Briacell therapeutics briacell therapeutics corp briacell.com”, the matching SEC registrant is BriaCell Therapeutics Corp., which trades as BCTX, BCTXL, BCTXZ and files under Central Index Key 1610820. EDGAR puts it in the “Pharmaceutical Preparations” industry code with British Columbia, Canada as its state or country of incorporation; its earlier registered name was Ansell Capital Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-06-26, across 323 filings on record. This is reference material, not trading advice.

Financial trend for BriaCell Therapeutics Corp. from annual reports, periods 2022-07-31 to 2025-07-31: net income (loss) went from -$26.84 million (2022-07-31) to -$26.31 million (2025-07-31), a change of +2.0%; total assets went from $42.58 million (2022-07-31) to $21.65 million (2025-07-31), a change of -49.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1610820, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures BriaCell Therapeutics Corp. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for BriaCell Therapeutics Corp. (CIK 1610820) lists its business address as 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, which helps confirm you are on the right company’s site.

Current reports. Of the 116 8-K or 6-K reports in BriaCell Therapeutics Corp.’s recent EDGAR index, the 4 listed here run from 2026-03-09 to 2026-06-26, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 323 recent EDGAR filings, BriaCell Therapeutics Corp. most often filed 8-K (65), 6-K (51), CORRESP (32), F-1/A (15). A selection from 2026-02-12 to 2026-06-09:

The full record for CIK 1610820 is on the EDGAR company page; the latest 10-K there is dated 2025-10-16 and the oldest filing in the recent index dates from 2014-06-20. Insider trades for BriaCell Therapeutics Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cemtrex cemtrex inc. cemtrex.com

Also searched as: "cemtrex" | "cemtrex inc." | "cemtrex.com"

For “Cemtrex cemtrex inc. cemtrex.com”, the matching SEC registrant is CEMTREX INC, which trades as CETX, CETXP and files under Central Index Key 1435064. EDGAR puts it in the “Construction - Special Trade Contractors” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-09, across 551 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2025-12-29 by CEMTREX INC (CIK 1435064) — source document:

Cemtrex, Inc. was incorporated in 1998 in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries. Security Cemtrex’s Security segment operates under the brand of its majority owned subsidiary, Vicon Industries, Inc. (“Vicon”), which provides end-to-end security solutions to meet the toughest corporate, industrial, and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices.

Financial trend for CEMTREX INC from annual reports, periods 2022-09-30 to 2025-09-30: net income (loss) went from -$13.02 million (2022-09-30) to -$28.11 million (2025-09-30), a change of -115.9%; total assets went from $45.76 million (2022-09-30) to $47.79 million (2025-09-30), a change of +4.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1435064, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures CEMTREX INC did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for CEMTREX INC (CIK 1435064) lists its business address as 276 GREENPOINT AVE. BLD 8 SUITE 208, BROOKLYN, NY, which helps confirm you are on the right company’s site.

Current reports. Of the 157 8-K or 6-K reports in CEMTREX INC’s recent EDGAR index, the 4 listed here run from 2026-06-02 to 2026-10-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1435064 is on the EDGAR company page; the latest 10-K/A there is dated 2026-01-16 and the oldest filing in the recent index dates from 2008-05-14. Insider trades for CEMTREX INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Chowchow cloud international serenoclouds.com

Also searched as: "chowchow cloud international" | "serenoclouds.com"

For “Chowchow cloud international serenoclouds.com”, the matching SEC registrant is ChowChow Cloud International Holdings Ltd, which trades as CHOW and files under Central Index Key 2041829. EDGAR puts it in the “Services-Prepackaged Software” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-21, across 46 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-05-15 by ChowChow Cloud International Holdings Ltd (CIK 2041829) — source document:

SCS is an operating company incorporated in Hong Kong on December 3, 2014, and Yee Kar Wing and Hui Wai Ming were its shareholders until September 26, 2023. As part of a restructuring exercise, Vigorous Elite Holdings Limited became the sole shareholder of SCS on September 26, 2023, and ChowChow Cloud International Holdings Limited was incorporated on October 8, 2024. On October 18, 2024, the Company subdivided its authorized share capital to US$50,000 divided into 500,000,000 Ordinary Shares of nominal or par value of US$0.0001 each. Subsequently, on October 24, 2024, the shareholders of Vigorous Elite Holdings Limited transferred all their shareholdings in Vigorous Elite Holdings Limited to the Company in consideration for shares in the Company resulting in the Company becoming the sole shareholder of Vigorous Elite Holdings Limited, and the ultimate holding company of SCS. Since our inception, we have focused on innovation in our cloud solutions and the application of emerging technologies such as cloud technology and AI. Our efforts are backed by our team of experts, deep understanding of evolving IT needs, high operational flexibility, and flat, efficient organization structure.

Financial trend for ChowChow Cloud International Holdings Ltd from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from 141,372,358 HKD (2023-12-31) to 251,216,649 HKD (2025-12-31), a change of +77.7%; net income (loss) went from 12,105,673 HKD (2023-12-31) to -23,550,966 HKD (2025-12-31), a change of -294.5%; total assets went from 47,682,310 HKD (2024-12-31) to 97,202,852 HKD (2025-12-31), a change of +103.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2041829, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures ChowChow Cloud International Holdings Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for ChowChow Cloud International Holdings Ltd (CIK 2041829) lists its business address as UNIT 03, 23/F., AITKEN VANSON CENTRE,, HONG KONG, Hong Kong, which helps confirm you are on the right company’s site.

Current reports. Of the 12 8-K or 6-K reports in ChowChow Cloud International Holdings Ltd’s recent EDGAR index, the 4 listed here run from 2026-09-15 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2041829 is on the EDGAR company page; the latest 20-F there is dated 2026-05-15 and the oldest filing in the recent index dates from 2024-10-25. Insider trades for ChowChow Cloud International Holdings Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Coastalstates bank coastalsouth bancshares coastalstatesbank.com

Also searched as: "coastalstates bank" | "coastalsouth bancshares" | "coastalstatesbank.com"

For “Coastalstates bank coastalsouth bancshares coastalstatesbank.com”, the matching SEC registrant is CoastalSouth Bancshares, Inc., which trades as COSO and files under Central Index Key 1297107. EDGAR puts it in the “State Commercial Banks” industry code with an unstated jurisdiction as its state or country of incorporation; its earlier registered name was Coastal South Bancshares Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 144 filed 2026-10-23, across 110 filings on record. This is reference material, not trading advice.

Financial trend for CoastalSouth Bancshares, Inc. from annual reports, periods 2024-12-31 to 2025-12-31: revenue went from $1.86 million (2024-12-31) to $1.99 million (2025-12-31), a change of +6.4%; net income (loss) went from $21.90 million (2024-12-31) to $24.89 million (2025-12-31), a change of +13.6%; total assets went from $2.10 billion (2024-12-31) to $2.31 billion (2025-12-31), a change of +9.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1297107, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 2 periods shown, dashes mark figures CoastalSouth Bancshares, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for CoastalSouth Bancshares, Inc. (CIK 1297107) lists its business address as 400 GALLERIA PKWY, ATLANTA, GA, which helps confirm you are on the right company’s site.

Current reports. Of the 12 8-K or 6-K reports in CoastalSouth Bancshares, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-01 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 110 recent EDGAR filings, CoastalSouth Bancshares, Inc. most often filed 4 (37), 3 (15), 8-K (12), D (6). A selection from 2026-08-26 to 2026-10-23:

The full record for CIK 1297107 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2004-07-09. Insider trades for CoastalSouth Bancshares, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cohen & steers infrastructure cohenandsteers

Also searched as: "cohen & steers infrastructure" | "cohenandsteers"

For “Cohen & steers infrastructure cohenandsteers”, the matching SEC registrant is COHEN & STEERS, INC., which trades as CNS and files under Central Index Key 1284812. EDGAR puts it in the “Investment Advice” industry code with DE as its state or country of incorporation; its earlier registered name was COHEN & STEERS INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-15, across 1004 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-27 by COHEN & STEERS, INC. (CIK 1284812) — source document:

Cohen & Steers, founded in 1986, is a global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore, we serve institutional and individual investors around the world. Cohen & Steers, Inc. (CNS) was organized as a Delaware corporation on March 17, 2004. CNS is the holding company for its direct and indirect subsidiaries, including Cohen & Steers Capital Management, Inc. (CSCM), Cohen & Steers Securities, LLC (CSS), Cohen & Steers UK Limited (CSUK), Cohen & Steers Ireland Limited (CSIL), Cohen & Steers Asia Limited (CSAL), Cohen & Steers Japan Limited (CSJL) and Cohen & Steers Singapore Private Limited (CSSG).

Financial trend for COHEN & STEERS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from $171.04 million (2022-12-31) to $153.22 million (2025-12-31), a change of -10.4%; total assets went from $673.38 million (2022-12-31) to $876.69 million (2025-12-31), a change of +30.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1284812, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures COHEN & STEERS, INC. did not tag for that period.

COHEN & STEERS, INC. has 1004 filings in its recent EDGAR index, including 6 annual reports and 20 quarterly reports; its newest filing is a 8-K from 2026-10-15.

Current reports. Of the 51 8-K or 6-K reports in COHEN & STEERS, INC.’s recent EDGAR index, the 4 listed here run from 2026-05-04 to 2026-10-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1284812 is on the EDGAR company page; the latest 10-K there is dated 2026-02-27 and the oldest filing in the recent index dates from 2020-04-03. Insider trades for COHEN & STEERS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Corbus pharmaceuticals corbus pharma corbuspharma.com

Also searched as: "corbus pharmaceuticals" | "corbus pharma" | "corbuspharma.com"

For “Corbus pharmaceuticals corbus pharma corbuspharma.com”, the matching SEC registrant is Corbus Pharmaceuticals Holdings, Inc., which trades as CRBP and files under Central Index Key 1595097. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was SAV Acquisition Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-15, across 805 filings on record. This is reference material, not trading advice.

Our pipeline is as follows: CRB-701 CRB-701 (SYS6002) is a novel clinical stage ADC that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of MMAE. In February 2023, the Company obtained a license from CSPC Megalith Biopharmaceutical Co. Ltd. (“CSPC”), a subsidiary of CSPC Pharmaceutical Group Limited, to develop and commercialize the drug in the United States (“U.S.”), Canada, the European Union (including the European Free Trade Area), the United Kingdom (“U.K.”) and Australia. The Company is conducting a Phase 1/2 study in the U.S. and Europe (the "Western study") enrolling patients with advanced solid tumors associated with Nectin-4 expression. The dose expansion phase of the clinical trial is ongoing.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Corbus Pharmaceuticals Holdings, Inc. (CIK 1595097) lists its business address as 500 RIVER RIDGE DRIVE, NORWOOD, MA, which helps confirm you are on the right company’s site.

Updated Oct 25, 2026 ET

Cullinan therapeutics cullinan therapeutics inc. cullinantherapeutics.com

Also searched as: "cullinan therapeutics" | "cullinan therapeutics inc." | "cullinantherapeutics.com"

For “Cullinan therapeutics cullinan therapeutics inc. cullinantherapeutics.com”, the matching SEC registrant is Cullinan Therapeutics, Inc., which trades as CGEM and files under Central Index Key 1789972. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Cullinan Oncology, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-02, across 464 filings on record. This is reference material, not trading advice.

Financial trend for Cullinan Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue was tagged only for 2022-12-31 at $0; net income (loss) went from $111.21 million (2022-12-31) to -$219.88 million (2025-12-31), a change of -297.7%; total assets went from $561.12 million (2022-12-31) to $448.37 million (2025-12-31), a change of -20.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1789972, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Cullinan Therapeutics, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Cullinan Therapeutics, Inc. (CIK 1789972) lists its business address as ONE MAIN STREET, CAMBRIDGE, MA, which helps confirm you are on the right company’s site.

Current reports. Of the 66 8-K or 6-K reports in Cullinan Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-08-13 to 2026-10-02, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 464 recent EDGAR filings, Cullinan Therapeutics, Inc. most often filed 4 (220), 8-K (66), 3 (27), 144 (20). A selection from 2026-08-14 to 2026-09-10:

The full record for CIK 1789972 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2020-11-02. Insider trades for Cullinan Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Dariohealth dariohealth corp. dariohealth.com

Also searched as: "dariohealth" | "dariohealth corp." | "dariohealth.com"

For “Dariohealth dariohealth corp. dariohealth.com”, the matching SEC registrant is DarioHealth Corp., which trades as DRIO and files under Central Index Key 1533998. EDGAR puts it in the “Surgical & Medical Instruments & Apparatus” industry code with DE as its state or country of incorporation; its earlier registered name was LabStyle Innovations Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-09-28, across 903 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-19 by DarioHealth Corp. (CIK 1533998) — source document:

Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, AI built on that proprietary data, and a behavior change and coaching layer validated through over 100 peer-reviewed clinical studies. We are committed to transforming healthcare by delivering a comprehensive and highly engaging whole-person health platform, which enables us to create a future where healthy change is effortless and accessible to all. ​ At the core of our mission and vision is engagement. We believe that most existing digital health solutions in the market fail to deliver improved health outcomes because users are not engaged due to a lack relevance, personalization, consumerization, and longitudinal data and information.

Financial trend for DarioHealth Corp. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$62.19 million (2022-12-31) to -$41.71 million (2025-12-31), a change of +32.9%; total assets went from $119.19 million (2022-12-31) to $110.08 million (2025-12-31), a change of -7.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1533998, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures DarioHealth Corp. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for DarioHealth Corp. (CIK 1533998) lists its business address as 322 W 57TH ST. #33B, NEW YORK, NY, which helps confirm you are on the right company’s site.

Current reports. Of the 145 8-K or 6-K reports in DarioHealth Corp.’s recent EDGAR index, the 4 listed here run from 2026-07-10 to 2026-09-04, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1533998 is on the EDGAR company page; the latest 10-K there is dated 2026-03-19 and the oldest filing in the recent index dates from 2011-11-01. Insider trades for DarioHealth Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Design therapeutics design therapeutics inc. designtx.com

Also searched as: "design therapeutics" | "design therapeutics inc." | "designtx.com"

For “Design therapeutics design therapeutics inc. designtx.com”, the matching SEC registrant is Design Therapeutics, Inc., which trades as DSGN and files under Central Index Key 1807120. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G/A filed 2026-08-14, across 264 filings on record. This is reference material, not trading advice.

Financial trend for Design Therapeutics, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $0 (2024-12-31) to $0 (2025-12-31); net income (loss) went from -$63.31 million (2022-12-31) to -$69.79 million (2025-12-31), a change of -10.2%; total assets went from $341.14 million (2022-12-31) to $226.20 million (2025-12-31), a change of -33.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1807120, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Design Therapeutics, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Design Therapeutics, Inc. (CIK 1807120) lists its business address as 6005 HIDDEN VALLEY ROAD, CARLSBAD, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 38 8-K or 6-K reports in Design Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2026-04-28 to 2026-08-03, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 264 recent EDGAR filings, Design Therapeutics, Inc. most often filed 4 (92), 8-K (38), 3 (23), 10-Q (17). A selection from 2026-06-11 to 2026-08-14:

The full record for CIK 1807120 is on the EDGAR company page; the latest 10-K there is dated 2026-03-09 and the oldest filing in the recent index dates from 2020-03-20. Insider trades for Design Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Easterly government properties easterlyreit.com

Also searched as: "easterly government properties" | "easterlyreit.com"

For “Easterly government properties easterlyreit.com”, the matching SEC registrant is Easterly Government Properties, Inc., which trades as DEA and files under Central Index Key 1622194. EDGAR puts it in the “Real Estate Investment Trusts” industry code with MD as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-08-05, across 608 filings on record. This is reference material, not trading advice.

Financial trend for Easterly Government Properties, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $293.61 million (2022-12-31) to $336.10 million (2025-12-31), a change of +14.5%; net income (loss) went from $31.47 million (2022-12-31) to $13.00 million (2025-12-31), a change of -58.7%; total assets went from $2.83 billion (2022-12-31) to $3.38 billion (2025-12-31), a change of +19.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1622194, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Easterly Government Properties, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Easterly Government Properties, Inc. (CIK 1622194) lists its business address as 2001 K STREET NW, WASHINGTON, DC, which helps confirm you are on the right company’s site.

Current reports. Of the 114 8-K or 6-K reports in Easterly Government Properties, Inc.’s recent EDGAR index, the 4 listed here run from 2026-04-27 to 2026-08-05, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 608 recent EDGAR filings, Easterly Government Properties, Inc. most often filed 4 (277), 8-K (114), SC 13G/A (37), 10-Q (35). A selection from 2026-04-30 to 2026-08-04:

The full record for CIK 1622194 is on the EDGAR company page; the latest 10-K there is dated 2026-02-23 and the oldest filing in the recent index dates from 2014-10-17. Insider trades for Easterly Government Properties, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Eloxx pharmaceuticals eloxx pharmaceuticals inc. eloxxpharma.com

Also searched as: "eloxx pharmaceuticals" | "eloxx pharmaceuticals inc." | "eloxxpharma.com"

For “Eloxx pharmaceuticals eloxx pharmaceuticals inc. eloxxpharma.com”, the matching SEC registrant is Eloxx Pharmaceuticals, Inc., which trades as ELOX and files under Central Index Key 1035354. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with DE as its state or country of incorporation; its earlier registered name was Sevion Therapeutics, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 424B3 filed 2026-10-22, across 1000 filings on record. This is reference material, not trading advice.

Financial trend for Eloxx Pharmaceuticals, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $0 (2023-12-31) to $0 (2025-12-31); net income (loss) went from -$36.06 million (2022-12-31) to -$6.00 million (2025-12-31), a change of +83.4%; total assets went from $21.12 million (2022-12-31) to $5.27 million (2025-12-31), a change of -75.1%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1035354, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Eloxx Pharmaceuticals, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Eloxx Pharmaceuticals, Inc. (CIK 1035354) lists its business address as P.O. BOX 274, ARLINGTON, MA, which helps confirm you are on the right company’s site.

Current reports. Of the 246 8-K or 6-K reports in Eloxx Pharmaceuticals, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-01 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 1000 recent EDGAR filings, Eloxx Pharmaceuticals, Inc. most often filed 4 (394), 8-K (246), 10-Q (47), 3 (42). A selection from 2026-09-11 to 2026-10-22:

The full record for CIK 1035354 is on the EDGAR company page; the latest 10-K there is dated 2026-03-17 and the oldest filing in the recent index dates from 2008-12-23. Insider trades for Eloxx Pharmaceuticals, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Exyn technologies exyn technologies inc. exyn.com

Also searched as: "exyn technologies" | "exyn technologies inc." | "exyn.com"

For “Exyn technologies exyn technologies inc. exyn.com”, the matching SEC registrant is Exyn Technologies, Inc., which trades as EXYN, EXYNW and files under Central Index Key 1960355. EDGAR puts it in the “Services-Prepackaged Software” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-08-25, across 49 filings on record. This is reference material, not trading advice.

Financial trend for Exyn Technologies, Inc. from quarterly and annual reports (three-month periods), periods 2025-06-30 to 2026-06-30: revenue went from $1.36 million (2025-06-30) to $949,604 (2026-06-30), a change of -30.1%; net income (loss) went from -$2.92 million (2025-06-30) to -$6.89 million (2026-06-30), a change of -135.9%; total assets went from $5.15 million (2026-03-31) to $11.76 million (2026-06-30), a change of +128.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1960355, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Exyn Technologies, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Exyn Technologies, Inc. (CIK 1960355) lists its business address as 2118 WASHINGTON AVENUE, PHILADELPHIA, PA, which helps confirm you are on the right company’s site.

Current reports. Of the 7 8-K or 6-K reports in Exyn Technologies, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-07 to 2026-08-25, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 49 recent EDGAR filings, Exyn Technologies, Inc. most often filed 3 (9), 8-K (7), S-1/A (7), 4 (5). A selection from 2026-08-14 to 2026-08-20:

The full record for CIK 1960355 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-12-04. Insider trades for Exyn Technologies, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fbs global fbs global limited fbsglobal.com.sg

Also searched as: "fbs global" | "fbs global limited" | "fbsglobal.com.sg"

For “Fbs global fbs global limited fbsglobal.com.sg”, the matching SEC registrant is FBS Global Ltd, which trades as FBGL and files under Central Index Key 1938534. EDGAR puts it in the “General Bldg Contractors - Residential Bldgs” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-13, across 99 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-30 by FBS Global Ltd (CIK 1938534) — source document:

Ltd. (“FBS SG”), which is held through Success Elite Developments Limited (“SEDL”), a wholly-owned subsidiary of the Company, and FBS Holdings Pte. Ltd., a wholly-owned subsidiary of SEDL. The Group also acquired Bright Bless Developments Limited (“BBDL”), a wholly-owned subsidiary of the Company, on March 7, 2025 as part of its expansion strategy. During the year, the Group entered into agreements to acquire equity interests in EFMK Supplies Limited (“EFMK”) through BBDL as part of its plan to expand into Hong Kong, Macau and the People’s Republic of China (“PRC”). However, as at the date of this report, the transfer of shares has not been completed and the Group has not obtained effective control over EFMK. Accordingly, EFMK is not consolidated as a subsidiary of the Group.

Financial trend for FBS Global Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 16,824,168 SGD (2022-12-31) to 25,860,705 SGD (2025-12-31), a change of +53.7%; net income (loss) went from 68,627 SGD (2022-12-31) to -2,036,143 SGD (2025-12-31), a change of -3067.0%; total assets went from 17,188,320 SGD (2022-12-31) to 27,837,378 SGD (2025-12-31), a change of +62.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1938534, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures FBS Global Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for FBS Global Ltd (CIK 1938534) lists its business address as 74 TAGORE LANE,, SINGAPORE, Singapore, which helps confirm you are on the right company’s site.

Current reports. Of the 14 8-K or 6-K reports in FBS Global Ltd’s recent EDGAR index, the 4 listed here run from 2026-09-14 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1938534 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2022-09-13. Insider trades for FBS Global Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fenbo holdings limited fenbo fenbo.com

Also searched as: "fenbo holdings limited" | "fenbo" | "fenbo.com"

For “Fenbo holdings limited fenbo fenbo.com”, the matching SEC registrant is Fenbo Holdings Ltd, which trades as FEBO and files under Central Index Key 1957001. EDGAR puts it in the “Electric Housewares & Fans” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-19, across 88 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-05-15 by Fenbo Holdings Ltd (CIK 1957001) — source document:

Through our Operating Subsidiaries, we have over 30 years of experience producing premium personal care electric appliances (principally electrical hair styling products such as straighteners, curlers, trimmers, etc.) and toy products to overseas markets. 35 Our operating history began in 1993 when FIL was founded in Hong Kong by Mr. Li Kin Shing as a toy manufacturer and distributor. As the toy market deteriorated, he founded AIL in 2005 in Hong Kong and shifted our operations to the manufacture and sale of personal care electric appliances. Our manufacturing subsidiary, FPPF, located in Guangdong, PRC, was formed in the PRC in 2010 and is capable of producing over three million units per year.

Financial trend for Fenbo Holdings Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 119,728,000 HKD (2022-12-31) to 85,023,000 HKD (2025-12-31), a change of -29.0%; net income (loss) went from 8,653,000 HKD (2022-12-31) to -10,643,000 HKD (2025-12-31), a change of -223.0%; total assets went from 79,936,000 HKD (2022-12-31) to 71,432,000 HKD (2025-12-31), a change of -10.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1957001, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Fenbo Holdings Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Fenbo Holdings Ltd (CIK 1957001) lists its business address as UNIT J, 19/F, WORLD TECH CENTRE, KWUN TONG, KOWLOON, Hong Kong, which helps confirm you are on the right company’s site.

Current reports. Of the 22 8-K or 6-K reports in Fenbo Holdings Ltd’s recent EDGAR index, the 4 listed here run from 2026-07-30 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1957001 is on the EDGAR company page; the latest 20-F there is dated 2026-05-15 and the oldest filing in the recent index dates from 2022-12-16. Insider trades for Fenbo Holdings Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fgi industries fgi industries ltd. fgiindustries.com

Also searched as: "fgi industries" | "fgi industries ltd." | "fgiindustries.com"

For “Fgi industries fgi industries ltd. fgiindustries.com”, the matching SEC registrant is FGI Industries Ltd., which trades as FGI, FGIWW and files under Central Index Key 1864943. EDGAR puts it in the “Heating Equip, Except Elec & Warm Air; & Plumbing Fixtures” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-08-14, across 148 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-04-10 by FGI Industries Ltd. (CIK 1864943) — source document:

FGI is a global, diversified and reputable supplier of quality bath and kitchen products. With over thirty years of experience, FGI has become a leading business to business supplier of bath and kitchen products to large retail, wholesale, commercial and specialty channel customers around the globe specializing in the home improvement and R&R (Repair & Remodel) markets. Some of our largest customers include The Home Depot, Menards, Ferguson and Lowe’s. Throughout our history, we have achieved consistent and above-industry sales growth each year by executing on our strategic objectives which include offering well-designed, high-quality products, providing service that surpasses our competition and exceeds our customers’ expectations, and managing an efficient and resilient global supply chain.

Financial trend for FGI Industries Ltd. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $161.72 million (2022-12-31) to $130.53 million (2025-12-31), a change of -19.3%; net income (loss) went from $3.68 million (2022-12-31) to -$6.14 million (2025-12-31), a change of -266.8%; total assets went from $60.37 million (2022-12-31) to $69.54 million (2025-12-31), a change of +15.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1864943, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures FGI Industries Ltd. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for FGI Industries Ltd. (CIK 1864943) lists its business address as 906 MURRAY ROAD, EAST HANOVER, NJ, which helps confirm you are on the right company’s site.

Current reports. Of the 33 8-K or 6-K reports in FGI Industries Ltd.’s recent EDGAR index, the 4 listed here run from 2026-04-23 to 2026-08-12, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1864943 is on the EDGAR company page; the latest 10-K there is dated 2026-04-10 and the oldest filing in the recent index dates from 2021-06-07. Insider trades for FGI Industries Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Foresight autonomous foresight autonomous holdings foresightauto.com

Also searched as: "foresight autonomous" | "foresight autonomous holdings" | "foresightauto.com"

For “Foresight autonomous foresight autonomous holdings foresightauto.com”, the matching SEC registrant is Foresight Autonomous Holdings Ltd., which trades as FRSX and files under Central Index Key 1691221. EDGAR puts it in the “Services-Prepackaged Software” industry code with Israel as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-20, across 405 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-03-25 by Foresight Autonomous Holdings Ltd. (CIK 1691221) — source document:

OPERATING AND FINANCIAL REVIEW AND PROSPECTS 44 A. Operating Results 44 B. Liquidity and Capital Resources 47 C. Research and Development, Patent and Licenses, etc. 50 D. Trend Information. 50 E. Critical Accounting Estimates 50 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 51 A. Directors and Senior Management 51 B. Compensation 54 C. Board Practices 56 D. Employees 70 E. Share Ownership 70 F. Action to Recover Erroneously Awarded Compensation 72 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 72 A. Major Shareholders 72 B. Related Party Transactions 75 C. Interests of Experts and Counsel 76 ITEM 8. FINANCIAL INFORMATION 76 A. Consolidated Statements and Other Financial Information 76 B. Significant Changes 76 ITEM 9.

Financial trend for Foresight Autonomous Holdings Ltd. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$21.68 million (2022-12-31) to -$12.10 million (2025-12-31), a change of +44.2%; total assets went from $32.89 million (2022-12-31) to $8.35 million (2025-12-31), a change of -74.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1691221, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Foresight Autonomous Holdings Ltd. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Foresight Autonomous Holdings Ltd. (CIK 1691221) lists its business address as 7 GOLDA MEIR ST.,, NESS ZIONA, Israel, which helps confirm you are on the right company’s site.

Current reports. Of the 294 8-K or 6-K reports in Foresight Autonomous Holdings Ltd.’s recent EDGAR index, the 4 listed here run from 2026-09-18 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1691221 is on the EDGAR company page; the latest 20-F there is dated 2026-03-25 and the oldest filing in the recent index dates from 2016-12-27. Insider trades for Foresight Autonomous Holdings Ltd. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Fury gold mines fury gold mines limited furygoldmines.com

Also searched as: "fury gold mines" | "fury gold mines limited" | "furygoldmines.com"

For “Fury gold mines fury gold mines limited furygoldmines.com”, the matching SEC registrant is FURY GOLD MINES LTD, which trades as FURY and files under Central Index Key 1514597. EDGAR puts it in the “Gold and Silver Ores” industry code with British Columbia, Canada as its state or country of incorporation; its earlier registered name was AURYN RESOURCES INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-08-25, across 356 filings on record. This is reference material, not trading advice.

Financial trend for FURY GOLD MINES LTD from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from 24,908,000 CAD (2022-12-31) to -6,459,000 CAD (2025-12-31), a change of -125.9%; total assets went from 200,599,000 CAD (2022-12-31) to 108,319,000 CAD (2025-12-31), a change of -46.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1514597, tags Assets, ProfitLoss; 4 periods shown, dashes mark figures FURY GOLD MINES LTD did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for FURY GOLD MINES LTD (CIK 1514597) lists its business address as 401 BAY STREET, TORONTO, Ontario, Canada, which helps confirm you are on the right company’s site.

Current reports. Of the 303 8-K or 6-K reports in FURY GOLD MINES LTD’s recent EDGAR index, the 4 listed here run from 2026-07-15 to 2026-08-25, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 356 recent EDGAR filings, FURY GOLD MINES LTD most often filed 6-K (303), D (8), 40-F (7), 6-K/A (6). A selection from 2025-06-25 to 2026-03-31:

The full record for CIK 1514597 is on the EDGAR company page; the latest 40-F there is dated 2026-03-31 and the oldest filing in the recent index dates from 2011-03-08. Insider trades for FURY GOLD MINES LTD appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Galiano gold galiano gold inc galianogold.com

Also searched as: "galiano gold" | "galiano gold inc" | "galianogold.com"

For “Galiano gold galiano gold inc galianogold.com”, the matching SEC registrant is Galiano Gold Inc., which trades as GAU and files under Central Index Key 1377757. EDGAR puts it in the “Mining & Quarrying of Nonmetallic Minerals (No Fuels)” industry code with British Columbia, Canada as its state or country of incorporation; its earlier registered name was Asanko Gold Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-13, across 646 filings on record. This is reference material, not trading advice.

Financial trend for Galiano Gold Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $0 (2023-12-31) to $447.77 million (2025-12-31); net income (loss) went from $40.81 million (2022-12-31) to -$30.80 million (2025-12-31), a change of -175.5%; total assets went from $179.89 million (2022-12-31) to $599.05 million (2025-12-31), a change of +233.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1377757, tags Assets, ProfitLoss, Revenue; 4 periods shown, dashes mark figures Galiano Gold Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Galiano Gold Inc. (CIK 1377757) lists its business address as 1640 - 1066 WEST HASTINGS STREET, VANCOUVER, which helps confirm you are on the right company’s site.

Current reports. Of the 487 8-K or 6-K reports in Galiano Gold Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-09 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 646 recent EDGAR filings, Galiano Gold Inc. most often filed 6-K (487), SC 13G/A (37), SC 13G (35), 40-F (15). A selection from 2026-05-13 to 2026-09-04:

The full record for CIK 1377757 is on the EDGAR company page; the latest 40-F there is dated 2026-03-12 and the oldest filing in the recent index dates from 2006-10-17. Insider trades for Galiano Gold Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Gigcapital8 gigcapital8 corp. gigcapital8.com

Also searched as: "gigcapital8" | "gigcapital8 corp." | "gigcapital8.com"

For “Gigcapital8 gigcapital8 corp. gigcapital8.com”, the matching SEC registrant is GigCapital8 Corp., which trades as GIW, GIWWR, GIWWU and files under Central Index Key 2080019. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 425 filed 2026-10-14, across 48 filings on record. This is reference material, not trading advice.

Financial trend for GigCapital8 Corp. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $0 (2025-09-30) to $0 (2026-06-30); net income (loss) went from -$81,610 (2025-09-30) to $1.99 million (2026-06-30), a change of +2540.7%; total assets went from $3.46 million (2025-09-30) to $260.68 million (2026-06-30), a change of +7433.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2080019, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures GigCapital8 Corp. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for GigCapital8 Corp. (CIK 2080019) lists its business address as 1731 EMBARCADERO RD., SUITE 200, PALO ALTO, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 6 8-K or 6-K reports in GigCapital8 Corp.’s recent EDGAR index, the 4 listed here run from 2025-10-23 to 2026-10-13, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 48 recent EDGAR filings, GigCapital8 Corp. most often filed 3 (9), SCHEDULE 13G (7), 8-K (6), 425 (5). A selection from 2026-08-05 to 2026-10-14:

The full record for CIK 2080019 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2025-08-11. Insider trades for GigCapital8 Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Global mofy metaverse limited global mofy metaverse global mofy globalmofy.cn

Also searched as: "global mofy metaverse limited" | "global mofy metaverse" | "global mofy" | "globalmofy.cn"

For “Global mofy metaverse limited global mofy metaverse global mofy globalmofy.cn”, the matching SEC registrant is Global Mofy AI Ltd, which trades as GMM and files under Central Index Key 1913749. EDGAR puts it in the “Services-Computer Programming, Data Processing, Etc.” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Global Mofy Metaverse Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-20, across 162 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-01-09 by Global Mofy AI Ltd (CIK 1913749) — source document:

As a holding company with no material operations, Global Mofy Cayman conducts its operations in China through Global Mofy China and its PRC subsidiaries. After the restructure that dissolved the VIE structure, Global Mofy Cayman now controls and receives the economic benefits of the PRC subsidiaries’ business operation, if any, through equity ownership. We do not use a VIE structure. The following diagram illustrates our corporate structure as of the date of this report. 47 Global Mofy Cayman is a Cayman Islands exempted company incorporated on September 29, 2021. As a holding company with no significant assets or operation, it conducts business in China through Global Mofy China and its subsidiaries.

Financial trend for Global Mofy AI Ltd from annual reports, periods 2022-09-30 to 2025-09-30: revenue went from $17.19 million (2022-09-30) to $55.94 million (2025-09-30), a change of +225.5%; net income (loss) went from -$267,222 (2022-09-30) to -$19.30 million (2025-09-30), a change of -7123.3%; total assets went from $8.53 million (2022-09-30) to $78.05 million (2025-09-30), a change of +815.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1913749, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Global Mofy AI Ltd did not tag for that period.

Global Mofy AI Ltd has 162 filings in its recent EDGAR index, including 3 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-20.

Current reports. Of the 73 8-K or 6-K reports in Global Mofy AI Ltd’s recent EDGAR index, the 4 listed here run from 2026-08-20 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1913749 is on the EDGAR company page; the latest 20-F there is dated 2026-01-09 and the oldest filing in the recent index dates from 2022-03-04. Insider trades for Global Mofy AI Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Gri bio gri bio inc. gribio.com

Also searched as: "gri bio" | "gri bio inc." | "gribio.com"

For “Gri bio gri bio inc. gribio.com”, the matching SEC registrant is GRI Bio, Inc., which trades as GRI and files under Central Index Key 1824293. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was Vallon Pharmaceuticals, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a ARS filed 2026-09-28, across 401 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-01-30 by GRI Bio, Inc. (CIK 1824293) — source document:

MINE SAFETY DISCLOSURES 73 PART II 74 ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUE R PURCHASES OF EQUITY SECURITIES 74 I TEM 6. [RESERVED] 74 I TEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION S 74 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE S ABOUT MARKET RISK 84 ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 84 I TEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 84 ITEM 9A. CONTROLS AND PROCEDURES 85 I TEM 9B. OTHER INFORMATION 87 ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 87 PART III 88 ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 88 ITEM 11.

Financial trend for GRI Bio, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$3.22 million (2022-12-31) to -$11.96 million (2025-12-31), a change of -271.7%; total assets went from $383,000 (2022-12-31) to $8.67 million (2025-12-31), a change of +2162.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1824293, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures GRI Bio, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for GRI Bio, Inc. (CIK 1824293) lists its business address as 2223 AVENIDA DE LA PLAYA, LA JOLLA, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 99 8-K or 6-K reports in GRI Bio, Inc.’s recent EDGAR index, the 4 listed here run from 2026-02-04 to 2026-09-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1824293 is on the EDGAR company page; the latest 10-K there is dated 2026-01-30 and the oldest filing in the recent index dates from 2020-09-11. Insider trades for GRI Bio, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Hennessy advisors

Also searched as: "hennessy advisors" after:2026-10-16

For “Hennessy advisors”, the matching SEC registrant is HENNESSY ADVISORS INC, which trades as HNNA and files under Central Index Key 1145255. EDGAR puts it in the “Investment Advice” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-01, across 1001 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2025-12-03 by HENNESSY ADVISORS INC (CIK 1145255) — source document:

Hennessy Advisors, Inc. (the “Company,” “we,” “us,” or “our”) is a publicly traded investment management firm whose primary business activity is providing investment advisory services to a family of 16 open-end mutual funds (collectively, the “Hennessy Mutual Funds”) and one exchange‑traded fund (“ETF”) branded as the Hennessy Funds. We are committed to providing superior service to investors and employing a consistent and disciplined approach to investing based on a buy‑and‑hold philosophy that rejects the idea of market timing. Our goal is to provide products that investors can have confidence in, knowing their money is invested as promised and with their best interests in mind. Our firm was founded on these principles over 35 years ago, and the same principles guide us today.

Financial trend for HENNESSY ADVISORS INC from annual reports, periods 2022-09-30 to 2025-09-30: net income (loss) went from $6.19 million (2022-09-30) to $9.96 million (2025-09-30), a change of +60.9%; total assets went from $143.65 million (2022-09-30) to $160.46 million (2025-09-30), a change of +11.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1145255, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures HENNESSY ADVISORS INC did not tag for that period.

HENNESSY ADVISORS INC has 1001 filings in its recent EDGAR index, including 19 annual reports and 60 quarterly reports; its newest filing is a 4 from 2026-10-01.

Current reports. Of the 180 8-K or 6-K reports in HENNESSY ADVISORS INC’s recent EDGAR index, the 4 listed here run from 2026-02-09 to 2026-08-05, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1145255 is on the EDGAR company page; the latest 10-K there is dated 2025-12-03 and the oldest filing in the recent index dates from 2005-01-27. Insider trades for HENNESSY ADVISORS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Home bancorp inc home bancorp home24bank.com

Also searched as: "home bancorp inc" | "home bancorp" | "home24bank.com"

For “Home bancorp inc home bancorp home24bank.com”, the matching SEC registrant is HOME BANCORP, INC., which trades as HBCP and files under Central Index Key 1436425. EDGAR puts it in the “Savings Institutions, Not Federally Chartered” industry code with LA as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-19, across 809 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-06 by HOME BANCORP, INC. (CIK 1436425) — source document:

Home Bancorp, Inc. (the “Company”) is a Louisiana corporation and the holding company for Home Bank, N.A. (the “Bank”). The Bank, which is headquartered in Lafayette, Louisiana and is a wholly-owned subsidiary of the Company, currently conducts business through 43 banking offices in the Acadiana, Baton Rouge, Greater New Orleans and Northshore (of Lake Pontchartrain) regions of south Louisiana, the Natchez region of west Mississippi and the Houston region of Texas. The Company is subject to regulation as a bank holding company by the Board of Governors of the Federal Reserve System (the “FRB” or the “Federal Reserve”). The Bank established HB Investment Fund I, LLC and HB Investment Fund II, LLC, wholly-owned subsidiaries of the Bank to invest in New Markets Tax Credits (“NMTC”) and Federal Tax Credits ("FTC") in our market areas.

Financial trend for HOME BANCORP, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $125.93 million (2022-12-31) to $193.77 million (2025-12-31), a change of +53.9%; net income (loss) went from $34.07 million (2022-12-31) to $46.06 million (2025-12-31), a change of +35.2%; total assets went from $3.23 billion (2022-12-31) to $3.49 billion (2025-12-31), a change of +8.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1436425, tags Assets, InterestAndDividendIncomeOperating, NetIncomeLoss; 4 periods shown, dashes mark figures HOME BANCORP, INC. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for HOME BANCORP, INC. (CIK 1436425) lists its business address as 503 KALISTE SALOOM ROAD, LAFAYETTE, LA, which helps confirm you are on the right company’s site.

Current reports. Of the 191 8-K or 6-K reports in HOME BANCORP, INC.’s recent EDGAR index, the 4 listed here run from 2026-07-06 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1436425 is on the EDGAR company page; the latest 10-K there is dated 2026-03-06 and the oldest filing in the recent index dates from 2008-06-06. Insider trades for HOME BANCORP, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Intchains group limited intchains group intchains

Also searched as: "intchains group limited" | "intchains group" | "intchains"

For “Intchains group limited intchains group intchains”, the matching SEC registrant is Intchains Group Ltd, which trades as ICG and files under Central Index Key 1895597. EDGAR puts it in the “Semiconductors & Related Devices” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-18, across 106 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-13 by Intchains Group Ltd (CIK 1895597) — source document:

We, Intchains Group Limited, are a holding company incorporated in the Cayman Islands and conduct our operations primarily through our PRC subsidiaries. We began our operations in December 2017 when Shanghai Intchains Technology Co., Ltd., or Shanghai Intchains, was founded in Shanghai, China. With the growth of our business and in order to facilitate international capital raising, we underwent an offshore reorganization in the second half of 2021. In June 2021, Intchains Group Limited was incorporated in the Cayman Islands as our offshore holding company. Shortly after its incorporation, Intchains Group Limited incorporated a wholly-owned subsidiary in the British Virgin Islands, or BVI, namely, Intchains Investment (BVI) Limited, or Intchains BVI. In October 2021, Intchains Global Limited, or Intchains Global, was incorporated in the BVI as a wholly-owned subsidiary of Intchains Group Limited.

Financial trend for Intchains Group Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 473,740,000 CNY (2022-12-31) to 220,864,000 CNY (2025-12-31), a change of -53.4%; net income (loss) went from 355,201,000 CNY (2022-12-31) to -47,532,000 CNY (2025-12-31), a change of -113.4%; total assets went from 953,131,000 CNY (2022-12-31) to 1,019,898,000 CNY (2025-12-31), a change of +7.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1895597, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Intchains Group Ltd did not tag for that period.

Intchains Group Ltd has 106 filings in its recent EDGAR index, including 4 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-09-18.

Current reports. Of the 27 8-K or 6-K reports in Intchains Group Ltd’s recent EDGAR index, the 4 listed here run from 2026-05-06 to 2026-09-18, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1895597 is on the EDGAR company page; the latest 20-F there is dated 2026-04-13 and the oldest filing in the recent index dates from 2022-01-18. Insider trades for Intchains Group Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jatt ii acquisition jatt ii acquisition corp. jattacquisition.com/jattii

Also searched as: "jatt ii acquisition" | "jatt ii acquisition corp." | "jattacquisition.com/jattii"

For “Jatt ii acquisition jatt ii acquisition corp. jattacquisition.com/jattii”, the matching SEC registrant is JATT II Acquisition Corp., which trades as JATT and files under Central Index Key 2112446. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 425 filed 2026-10-01, across 46 filings on record. This is reference material, not trading advice.

Deal and listing documents for JATT II Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 9 such filings (424B4, 425, S-1, S-1/A) appear in its recent index, the newest dated 2026-10-01.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for JATT II Acquisition Corp. (CIK 2112446) lists its business address as C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, GEORGE TOWN, which helps confirm you are on the right company’s site.

Current reports. Of the 3 8-K or 6-K reports in JATT II Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2026-04-21 to 2026-06-29, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 46 recent EDGAR filings, JATT II Acquisition Corp. most often filed SCHEDULE 13G (7), 3 (7), 425 (6), CORRESP (6). A selection from 2026-09-10 to 2026-10-01:

The full record for CIK 2112446 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-03-13. Insider trades for JATT II Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jianzhi education jianzhi education technology jianzhijiaoyu.com

Also searched as: "jianzhi education" | "jianzhi education technology" | "jianzhijiaoyu.com"

For “Jianzhi education jianzhi education technology jianzhijiaoyu.com”, the matching SEC registrant is Jianzhi Education Technology Group Co Ltd, which trades as JZ and files under Central Index Key 1852440. EDGAR puts it in the “Services-Educational Services” industry code with Cayman Islands as its state or country of incorporation; its earlier registered name was Jianzhi Education Technology Group. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-01, across 113 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-13 by Jianzhi Education Technology Group Co Ltd (CIK 1852440) — source document:

In May 2011, Beijing Sentu Huarui Education Technology Co., Ltd., or Sentu Huarui, the predecessor company of Beijing Sentu, was established as a limited liability company in the PRC. In December 2015, Sentu Huarui was converted from a limited liability company into a joint stock limited liability company and renamed Beijing Sentu Education Technology Co., Ltd., or Beijing Sentu. In May 2016, Beijing Sentu was listed on the National Equities Exchange and Quotations, or NEEQ in the People’s Republic of China (stock code: 837329). However, as the liquidity of shares traded on NEEQ is comparatively low, Beijing Sentu voluntarily ceased to quote its shares on the NEEQ on November 7, 2017.

Financial trend for Jianzhi Education Technology Group Co Ltd from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from 505,724,311 CNY (2022-12-31) to 70,179,033 CNY (2025-12-31), a change of -86.1%; net income (loss) went from -199,161,807 CNY (2022-12-31) to -15,738,687 CNY (2025-12-31), a change of +92.1%; total assets went from 727,323,006 CNY (2022-12-31) to 105,278,857 CNY (2025-12-31), a change of -85.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1852440, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Jianzhi Education Technology Group Co Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Jianzhi Education Technology Group Co Ltd (CIK 1852440) lists its business address as YINGDU BUILDING, BEIJING, China, which helps confirm you are on the right company’s site.

Current reports. Of the 29 8-K or 6-K reports in Jianzhi Education Technology Group Co Ltd’s recent EDGAR index, the 4 listed here run from 2026-07-01 to 2026-09-01, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1852440 is on the EDGAR company page; the latest 20-F there is dated 2026-04-13 and the oldest filing in the recent index dates from 2021-03-26. Insider trades for Jianzhi Education Technology Group Co Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jiuzi holdings jzxn ningxia jiaze renewables

Also searched as: "jiuzi holdings" | "jzxn" | "ningxia jiaze renewables"

For “Jiuzi holdings jzxn ningxia jiaze renewables”, the matching SEC registrant is Jiuzi Holdings, Inc., which trades as JZXN and files under Central Index Key 1816172. EDGAR puts it in the “Retail-Auto Dealers & Gasoline Stations” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-08-24, across 192 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-02-24 by Jiuzi Holdings, Inc. (CIK 1816172) — source document:

We conduct our business in China through our PRC Operating Subsidiaries. The consolidation of our Company and our subsidiaries has been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying consolidated financial statements. Jiuzi HK was incorporated on October 25, 2019 under the law of Hong Kong SAR. Jiuzi HK is our wholly-owned subsidiary and is currently not engaging in any active business and merely acting as a holding company. Jiuzi WFOE was incorporated on June 5, 2020 under the laws of the People’s Republic of China. It is a wholly-owned subsidiary of Jiuzi HK and a wholly foreign-owned entity under the PRC laws.

Financial trend for Jiuzi Holdings, Inc. from annual reports, periods 2023-10-31 to 2025-10-31: revenue went from $5.93 million (2023-10-31) to $2.88 million (2025-10-31), a change of -51.4%; net income (loss) was tagged only for 2023-10-31 at -$9.39 million; total assets went from $11.39 million (2023-10-31) to $17.18 million (2025-10-31), a change of +50.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1816172, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Jiuzi Holdings, Inc. did not tag for that period.

Jiuzi Holdings, Inc. has 192 filings in its recent EDGAR index, including 5 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-08-24.

Current reports. Of the 88 8-K or 6-K reports in Jiuzi Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-08-24, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1816172 is on the EDGAR company page; the latest 20-F there is dated 2026-02-24 and the oldest filing in the recent index dates from 2020-07-08. Insider trades for Jiuzi Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Kairos pharma kairos pharma ltd kairospharma.com

Also searched as: "kairos pharma" | "kairos pharma ltd" | "kairospharma.com"

For “Kairos pharma kairos pharma ltd kairospharma.com”, the matching SEC registrant is Kairos Pharma, LTD., which trades as KAPA and files under Central Index Key 1962011. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-06, across 123 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by Kairos Pharma, LTD. (CIK 1962011) — source document:

We are a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. We are driven by innovative science to develop novel and transformative drug therapies to treat cancer. Our mission is to advance our portfolio of innovative therapeutics to target key mechanisms of therapeutic resistance and immune suppression and transform the way cancer is treated. We have leveraged molecular insights of the mechanisms of therapeutic resistance and immune suppression to develop a new class of novel drugs that we expect will target drug resistance and checkpoints of immune suppression.

Financial trend for Kairos Pharma, LTD. from annual reports, periods 2023-12-31 to 2025-12-31: net income (loss) went from -$1.81 million (2023-12-31) to -$5.45 million (2025-12-31), a change of -200.6%; total assets went from $965,000 (2023-12-31) to $6.54 million (2025-12-31), a change of +577.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1962011, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Kairos Pharma, LTD. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Kairos Pharma, LTD. (CIK 1962011) lists its business address as 2355 WESTWOOD BLVD. #139, LOS ANGELES, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 32 8-K or 6-K reports in Kairos Pharma, LTD.’s recent EDGAR index, the 4 listed here run from 2026-07-22 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1962011 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2023-03-29. Insider trades for Kairos Pharma, LTD. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Klx energy services klx energy services holdings klxenergy.com

Also searched as: "klx energy services" | "klx energy services holdings" | "klxenergy.com"

For “Klx energy services klx energy services holdings klxenergy.com”, the matching SEC registrant is KLX Energy Services Holdings, Inc., which trades as KLXE and files under Central Index Key 1738827. EDGAR puts it in the “Oil & Gas Field Services, NEC” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 3/A filed 2026-10-09, across 554 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-12 by KLX Energy Services Holdings, Inc. (CIK 1738827) — source document:

"Management Discussion and Analysis of Financial Condition and Results of Operations" for more details of our acquisitions since becoming a publicly traded company, including our 2020 acquisition of Quintana Energy Services Inc. (“QES,” and such acquisition the “QES Merger”) and our 2023 acquisition of Greene's Energy Group, LLC (“Greene's,” and such acquisition the “Greene's Acquisition”). We deliver mission critical oilfield services to primarily independent major oil and gas companies focused on drilling, completion, production and intervention activities for technically demanding wells from over 60 service facilities located in the United States. Our primary services include directional drilling, coiled tubing, thru tubing, hydraulic frac rentals, fishing, pressure control, wireline, rig-assisted snubbing, fluid pumping, flowback, testing, pressure pumping and well control services.

Financial trend for KLX Energy Services Holdings, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $781.60 million (2022-12-31) to $636.60 million (2025-12-31), a change of -18.6%; net income (loss) went from -$3.10 million (2022-12-31) to -$77.10 million (2025-12-31), a change of -2387.1%; total assets went from $465.90 million (2022-12-31) to $340.30 million (2025-12-31), a change of -27.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1738827, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures KLX Energy Services Holdings, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for KLX Energy Services Holdings, Inc. (CIK 1738827) lists its business address as 3040 POST OAK BOULEVARD, HOUSTON, TX, which helps confirm you are on the right company’s site.

Current reports. Of the 102 8-K or 6-K reports in KLX Energy Services Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-09-18 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1738827 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2018-06-21. Insider trades for KLX Energy Services Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Kochav defense kochav defense acquisition

Also searched as: "kochav defense" | "kochav defense acquisition"

For “Kochav defense kochav defense acquisition”, the matching SEC registrant is Kochav Defense Acquisition Corp., which trades as KCHV, KCHVR, KCHVU and files under Central Index Key 2053799. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a DEF 14A filed 2026-10-19, across 51 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by Kochav Defense Acquisition Corp. (CIK 2053799) — source document:

While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we are focused on industries that complement our Management Team’s background, and capitalizing on the ability of our Management Team to identify and acquire a business, focusing on the defense and aerospace industries. Initial Public Offering Our IPO Registration Statement became effective on May 27, 2025. On May 29, 2025, we consummated our Initial Public Offering of 25,300,000 Public Units, including 3,300,000 Option Units issued pursuant to the full exercise of the Over-Allotment Option. Each Public Unit consists of one Public Share and one Public Right. The Public Units were sold at a price of $10.00 per Public Unit, generating gross proceeds to us of $253,000,000.

Financial trend for Kochav Defense Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from $2.42 million (2025-09-30) to $2.13 million (2026-06-30), a change of -12.1%; total assets went from $257.56 million (2025-09-30) to $263.97 million (2026-06-30), a change of +2.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2053799, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Kochav Defense Acquisition Corp. did not tag for that period.

Deal and listing documents for Kochav Defense Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-05-28.

Current reports. Of the 3 8-K or 6-K reports in Kochav Defense Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2025-05-29 to 2025-07-16, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2053799 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2025-02-26. Insider trades for Kochav Defense Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lexaria bioscience lexaria bioscience corp lexariabioscience.com

Also searched as: "lexaria bioscience" | "lexaria bioscience corp" | "lexariabioscience.com"

For “Lexaria bioscience lexaria bioscience corp lexariabioscience.com”, the matching SEC registrant is Lexaria Bioscience Corp., which trades as LEXX and files under Central Index Key 1348362. EDGAR puts it in the “Pharmaceutical Preparations” industry code with NV as its state or country of incorporation; its earlier registered name was Lexaria Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a EFFECT filed 2026-10-13, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2025-11-28 by Lexaria Bioscience Corp. (CIK 1348362) — source document:

DehydraTECH can be implemented in a multitude of ingestible product formats including oral suspensions, tablets, capsules, foods, beverages, and oral pouches. It is suitable for use with a variety of product formats including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. DehydraTECH is a technology incorporated into the formulation and manufacturing process of new or existing orally ingestible products. The procedure involves combining the active ingredient as a delivery “payload” together with certain long chain fatty acid-rich triglyceride oils and infusing the mixture into a carrier substrate material. Using controlled dehydration processing, the payload and long chain fatty acid-rich triglyceride oils are reversibly associated together at a molecular level. The newly combined molecules are then integrated into production of the end-product using any number of dosage formats.

Financial trend for Lexaria Bioscience Corp. from annual reports, periods 2022-08-31 to 2025-08-31: revenue went from $255,397 (2022-08-31) to $705,923 (2025-08-31), a change of +176.4%; net income (loss) went from -$7.27 million (2022-08-31) to -$11.90 million (2025-08-31), a change of -63.7%; total assets went from $7.83 million (2022-08-31) to $4.18 million (2025-08-31), a change of -46.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1348362, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Lexaria Bioscience Corp. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Lexaria Bioscience Corp. (CIK 1348362) lists its business address as 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, which helps confirm you are on the right company’s site.

Current reports. Of the 349 8-K or 6-K reports in Lexaria Bioscience Corp.’s recent EDGAR index, the 4 listed here run from 2026-08-10 to 2026-09-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1348362 is on the EDGAR company page; the latest 10-K there is dated 2025-11-28 and the oldest filing in the recent index dates from 2009-08-25. Insider trades for Lexaria Bioscience Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lexeo therapeutics inc lexeo therapeutics lexeotx.com

Also searched as: "lexeo therapeutics inc" | "lexeo therapeutics" | "lexeotx.com"

For “Lexeo therapeutics inc lexeo therapeutics lexeotx.com”, the matching SEC registrant is Lexeo Therapeutics, Inc., which trades as LXEO and files under Central Index Key 1907108. EDGAR puts it in the “Biological Products, (No Diagnostic Substances)” industry code with an unstated jurisdiction as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G filed 2026-10-13, across 359 filings on record. This is reference material, not trading advice.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Lexeo Therapeutics, Inc. (CIK 1907108) lists its business address as 345 PARK AVENUE SOUTH, NEW YORK, NY, which helps confirm you are on the right company’s site.

Updated Oct 25, 2026 ET

Lexicon pharmaceuticals lexicon pharmaceuticals inc. lexpharma.com

Also searched as: "lexicon pharmaceuticals" | "lexicon pharmaceuticals inc." | "lexpharma.com"

For “Lexicon pharmaceuticals lexicon pharmaceuticals inc. lexpharma.com”, the matching SEC registrant is LEXICON PHARMACEUTICALS, INC., which trades as LXRX and files under Central Index Key 1062822. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was LEXICON PHARMACEUTICALS, INC./DE. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a EFFECT filed 2026-08-14, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-05 by LEXICON PHARMACEUTICALS, INC. (CIK 1062822) — source document:

We are a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. We are devoting most of our resources to the research and development of our most advanced drug candidates and the commercialization of our approved drug, INPEFA ® (sotagliflozin): • We are developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for hypertrophic cardiomyopathy, or HCM, and are conducting the SONATA-HCM pivotal Phase 3 clinical trial of sotagliflozin in that indication. • We are separately pursuing regulatory approval of ZYNQUISTA ® (sotagliflozin) as a treatment for type 1 diabetes. The U.S. Food and Drug Administration, or FDA, issued complete response letters regarding our New Drug Application, or NDA, for ZYNQUISTA in type 1 diabetes in March 2019 and December 2024.

Financial trend for LEXICON PHARMACEUTICALS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $139,000 (2022-12-31) to $49.80 million (2025-12-31), a change of +35729.5%; net income (loss) went from -$101.94 million (2022-12-31) to -$50.34 million (2025-12-31), a change of +50.6%; total assets went from $194.30 million (2022-12-31) to $184.99 million (2025-12-31), a change of -4.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1062822, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures LEXICON PHARMACEUTICALS, INC. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for LEXICON PHARMACEUTICALS, INC. (CIK 1062822) lists its business address as 2445 TECHNOLOGY FOREST BLVD., THE WOODLANDS, TX, which helps confirm you are on the right company’s site.

Current reports. Of the 180 8-K or 6-K reports in LEXICON PHARMACEUTICALS, INC.’s recent EDGAR index, the 4 listed here run from 2026-04-30 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1062822 is on the EDGAR company page; the latest 10-K there is dated 2026-03-05 and the oldest filing in the recent index dates from 2010-01-08. Insider trades for LEXICON PHARMACEUTICALS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Locafy locafy limited locafy.com

Also searched as: "locafy" | "locafy limited" | "locafy.com"

For “Locafy locafy limited locafy.com”, the matching SEC registrant is Locafy Ltd, which trades as LCFY, LCFYW and files under Central Index Key 1875547. EDGAR puts it in the “Services-Computer Programming, Data Processing, Etc.” industry code with Australia as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-06, across 113 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2025-11-12 by Locafy Ltd (CIK 1875547) — source document:

We were incorporated on April 23, 2009 in Australia under the name Gumiyo Australia Pty Ltd. On January 14, 2021, we changed our name to Locafy Limited. Our principal executive offices are located at 246 Churchill Avenue, Subiaco, Western Australia 6008, Australia and our telephone number is +61 409 999 339. On March 25, 2022, we completed our initial public offering in the United States. Our ordinary shares and warrants are listed on Nasdaq under the symbols “LCFY” and “LCFYW”, respectively. Our website address is www.locafy.com . The information contained on, or that can be accessed through, our website is not a part of this Annual Report. We have included our website address in this Annual Report solely as an inactive textual reference.

Financial trend for Locafy Ltd from annual reports, periods 2022-06-30 to 2025-06-30: net income (loss) went from -5,090,327 AUD (2022-06-30) to -4,314,231 AUD (2025-06-30), a change of +15.2%; total assets went from 8,554,930 AUD (2022-06-30) to 5,827,095 AUD (2025-06-30), a change of -31.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1875547, tags Assets, ProfitLoss; 4 periods shown, dashes mark figures Locafy Ltd did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Locafy Ltd (CIK 1875547) lists its business address as 246A CHURCHILL AVENUE, SUBIACO WA, Australia, which helps confirm you are on the right company’s site.

Current reports. Of the 59 8-K or 6-K reports in Locafy Ltd’s recent EDGAR index, the 4 listed here run from 2025-11-26 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1875547 is on the EDGAR company page; the latest 20-F there is dated 2025-11-12 and the oldest filing in the recent index dates from 2021-09-27. Insider trades for Locafy Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Maison solutions maison solutions inc maisonsolutionsinc.com

Also searched as: "maison solutions" | "maison solutions inc" | "maisonsolutionsinc.com"

For “Maison solutions maison solutions inc maisonsolutionsinc.com”, the matching SEC registrant is Maison Solutions Inc., which trades as MSS and files under Central Index Key 1892292. EDGAR puts it in the “Retail-Grocery Stores” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-29, across 164 filings on record. This is reference material, not trading advice.

Financial trend for Maison Solutions Inc. from annual reports, periods 2022-04-30 to 2025-04-30: revenue went from $41.98 million (2022-04-30) to $124.22 million (2025-04-30), a change of +195.9%; net income (loss) went from $655,026 (2022-04-30) to $1.17 million (2025-04-30), a change of +78.5%; total assets went from $26.10 million (2022-04-30) to $77.36 million (2025-04-30), a change of +196.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1892292, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Maison Solutions Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Maison Solutions Inc. (CIK 1892292) lists its business address as 127 N GARFIELD AVE, MONTEREY PARK, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 51 8-K or 6-K reports in Maison Solutions Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-27 to 2026-09-29, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 164 recent EDGAR filings, Maison Solutions Inc. most often filed 8-K (51), CORRESP (11), 3 (10), S-1/A (10). A selection from 2026-08-21 to 2026-09-18:

The full record for CIK 1892292 is on the EDGAR company page; the latest 10-K/A there is dated 2025-08-28 and the oldest filing in the recent index dates from 2022-12-23. Insider trades for Maison Solutions Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mbx biosciences mbx biosciences inc mbxbio.com

Also searched as: "mbx biosciences" | "mbx biosciences inc" | "mbxbio.com"

For “Mbx biosciences mbx biosciences inc mbxbio.com”, the matching SEC registrant is MBX Biosciences, Inc., which trades as MBX and files under Central Index Key 1776111. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-22, across 229 filings on record. This is reference material, not trading advice.

Financial trend for MBX Biosciences, Inc. from annual reports, periods 2023-12-31 to 2025-12-31: net income (loss) went from -$32.56 million (2023-12-31) to -$86.97 million (2025-12-31), a change of -167.1%; total assets went from $84.18 million (2023-12-31) to $385.14 million (2025-12-31), a change of +357.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1776111, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures MBX Biosciences, Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for MBX Biosciences, Inc. (CIK 1776111) lists its business address as 11711 N. MERIDIAN STREET, CARMEL, IN, which helps confirm you are on the right company’s site.

Current reports. Of the 28 8-K or 6-K reports in MBX Biosciences, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-13 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 229 recent EDGAR filings, MBX Biosciences, Inc. most often filed 4 (69), 8-K (28), 3 (26), 144 (17). A selection from 2026-08-10 to 2026-10-22:

The full record for CIK 1776111 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2019-05-10. Insider trades for MBX Biosciences, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Neptune insurance neptune insurance holdings neptuneflood.com

Also searched as: "neptune insurance" | "neptune insurance holdings" | "neptuneflood.com"

For “Neptune insurance neptune insurance holdings neptuneflood.com”, the matching SEC registrant is Neptune Insurance Holdings Inc., which trades as NP and files under Central Index Key 2067129. EDGAR puts it in the “Insurance Agents, Brokers & Service” industry code with DE as its state or country of incorporation; its earlier registered name was Neptune Insurance Holdings, Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 10-Q filed 2026-10-22, across 98 filings on record. This is reference material, not trading advice.

Financial trend for Neptune Insurance Holdings Inc. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $84.87 million (2023-12-31) to $159.55 million (2025-12-31), a change of +88.0%; net income (loss) went from $17.89 million (2023-12-31) to $37.41 million (2025-12-31), a change of +109.2%; total assets went from $48.15 million (2024-12-31) to $65.30 million (2025-12-31), a change of +35.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2067129, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 3 periods shown, dashes mark figures Neptune Insurance Holdings Inc. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Neptune Insurance Holdings Inc. (CIK 2067129) lists its business address as 400 6TH ST S, ST. PETERSBURG, FL, which helps confirm you are on the right company’s site.

Current reports. Of the 8 8-K or 6-K reports in Neptune Insurance Holdings Inc.’s recent EDGAR index, the 4 listed here run from 2026-06-01 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 98 recent EDGAR filings, Neptune Insurance Holdings Inc. most often filed 4 (29), 3 (10), 8-K (8), 144 (5). A selection from 2026-10-02 to 2026-10-22:

The full record for CIK 2067129 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2025-05-12. Insider trades for Neptune Insurance Holdings Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Newhold investment newhold investment corp iv nhicspac

Also searched as: "newhold investment" | "newhold investment corp iv" | "nhicspac"

For “Newhold investment newhold investment corp iv nhicspac”, the matching SEC registrant is NewHold Investment Corp IV, which trades as NHIV, NHIVU, NHIVW and files under Central Index Key 2099767. EDGAR puts it in the “Blank Checks” industry code with Cayman Islands as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a SCHEDULE 13G filed 2026-09-28, across 35 filings on record. This is reference material, not trading advice.

Financial trend for NewHold Investment Corp IV from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from -$38,000 (2026-03-31) to $854,000 (2026-06-30), a change of +2347.4%; total assets went from $281,000 (2026-03-31) to $204.31 million (2026-06-30), a change of +72609.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2099767, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures NewHold Investment Corp IV did not tag for that period.

Deal and listing documents for NewHold Investment Corp IV — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-04-16.

Current reports. Of the 3 8-K or 6-K reports in NewHold Investment Corp IV’s recent EDGAR index, the 3 listed here run from 2026-04-20 to 2026-07-22, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 35 recent EDGAR filings, NewHold Investment Corp IV most often filed 3 (13), SCHEDULE 13G (5), 8-K (3), 10-Q (2). A selection from 2026-08-14 to 2026-09-28:

The full record for CIK 2099767 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-12-08. Insider trades for NewHold Investment Corp IV appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nexpoint residential nexpoint residential trust nexpoint residential trust

Also searched as: "nexpoint residential" | "nexpoint residential trust" | "nexpoint residential trust"

For “Nexpoint residential nexpoint residential trust nexpoint residential trust”, the matching SEC registrant is NexPoint Residential Trust, Inc., which trades as NXRT and files under Central Index Key 1620393. EDGAR puts it in the “Real Estate Investment Trusts” industry code with MD as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 4 filed 2026-10-05, across 696 filings on record. This is reference material, not trading advice.

Financial trend for NexPoint Residential Trust, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $263.95 million (2022-12-31) to $251.28 million (2025-12-31), a change of -4.8%; net income (loss) went from -$9.26 million (2022-12-31) to -$32.03 million (2025-12-31), a change of -245.9%; total assets went from $2.23 billion (2022-12-31) to $1.89 billion (2025-12-31), a change of -15.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1620393, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures NexPoint Residential Trust, Inc. did not tag for that period.

NexPoint Residential Trust, Inc. has 696 filings in its recent EDGAR index, including 11 annual reports and 35 quarterly reports; its newest filing is a 4 from 2026-10-05.

Current reports. Of the 98 8-K or 6-K reports in NexPoint Residential Trust, Inc.’s recent EDGAR index, the 4 listed here run from 2026-04-28 to 2026-08-04, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 696 recent EDGAR filings, NexPoint Residential Trust, Inc. most often filed 4 (406), 8-K (98), 10-Q (35), SC 13G/A (26). A selection from 2026-08-05 to 2026-10-05:

The full record for CIK 1620393 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2014-09-29. Insider trades for NexPoint Residential Trust, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nomad power solutions nomad power solutions inc. nomadpower.com

Also searched as: "nomad power solutions" | "nomad power solutions inc." | "nomadpower.com"

For “Nomad power solutions nomad power solutions inc. nomadpower.com”, the matching SEC registrant is NOMAD POWER SOLUTIONS, INC., which trades as NMAD and files under Central Index Key 1335105. EDGAR puts it in the “Pharmaceutical Preparations” industry code with DE as its state or country of incorporation; its earlier registered name was LIXTE BIOTECHNOLOGY HOLDINGS, INC. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-06, across 527 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by NOMAD POWER SOLUTIONS, INC. (CIK 1335105) — source document:

Liora’s proprietary technology, known as LiGHT System (Linac for Image Guided Hadron Therapy), has significant advantages over currently available technologies for treating tumors with proton therapy. Liora is an excellent complement to the pharmaceutical side of the Company’s business and ongoing clinical trials with LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer, LB-100 The Company believes that the mechanism by which LB-100 affects cancer cell growth is different from cancer agents currently approved for clinical use. LB-100 is currently being tested in clinical trials in Ovarian Clear Cell Carcinoma, Metastatic Micro Satellite Stable (MSS) Colon Cancer, and Advanced Soft Tissue Sarcoma. LB-100 has shown anti-cancer activity in animal models of glioblastoma multiforme, neuroblastoma, and medulloblastoma, all cancers of neural tissue.

Financial trend for NOMAD POWER SOLUTIONS, INC. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$6.31 million (2022-12-31) to -$6.08 million (2025-12-31), a change of +3.7%; total assets went from $5.56 million (2022-12-31) to $12.73 million (2025-12-31), a change of +129.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1335105, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures NOMAD POWER SOLUTIONS, INC. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for NOMAD POWER SOLUTIONS, INC. (CIK 1335105) lists its business address as 433 PLAZA REAL, BOCA RATON, FL, which helps confirm you are on the right company’s site.

Current reports. Of the 143 8-K or 6-K reports in NOMAD POWER SOLUTIONS, INC.’s recent EDGAR index, the 4 listed here run from 2026-07-10 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1335105 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2005-08-03. Insider trades for NOMAD POWER SOLUTIONS, INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nomadar nomadar corp. nomadar.com

Also searched as: "nomadar" | "nomadar corp." | "nomadar.com"

For “Nomadar nomadar corp. nomadar.com”, the matching SEC registrant is Nomadar Corp., which trades as NOMA and files under Central Index Key 1994214. EDGAR puts it in the “Services-Amusement & Recreation Services” industry code with DE as its state or country of incorporation; its earlier registered name was Sportech City USA, Corp. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-09-14, across 88 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-31 by Nomadar Corp. (CIK 1994214) — source document:

We were incorporated in the State of Delaware in August 2023 as Sportech City USA, Corp, and changed our name to Nomadar Corp. in December 2023 (“Nomadar” or the “Company”). We are a subsidiary of Sport City Cádiz, S.L. (“Sportech”). Sportech is a wholly-owned subsidiary of Cádiz Club de Fútbol, S.A.D., a Spanish professional soccer club based in Cádiz, Andalusia (“Cádiz CF”) that competes in Campeonato Nacional de Liga de Segunda División, better known as the Segunda División (“Segunda División”) of Liga Nacional de Fútbol Profesional, better known as La Liga (“La Liga”). Our common stock began trading on the Nasdaq Capital Market on October 31, 2025 under the symbol “NOMA”.

Financial trend for Nomadar Corp. from annual reports, periods 2024-12-31 to 2025-12-31: revenue was tagged only for 2025-12-31 at $6,376; net income (loss) went from -$1.37 million (2024-12-31) to -$2.77 million (2025-12-31), a change of -101.6%; total assets went from $16,657 (2024-12-31) to $14.09 million (2025-12-31), a change of +84494.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1994214, tags Assets, NetIncomeLoss, Revenues; 2 periods shown, dashes mark figures Nomadar Corp. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Nomadar Corp. (CIK 1994214) lists its business address as 5015 HIGHWAY 59 N, MARSHALL, TX, which helps confirm you are on the right company’s site.

Current reports. Of the 18 8-K or 6-K reports in Nomadar Corp.’s recent EDGAR index, the 4 listed here run from 2026-07-06 to 2026-09-14, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1994214 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2023-10-13. Insider trades for Nomadar Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Northeast community bancorp northeast community bank necommunitybank.com

Also searched as: "northeast community bancorp" | "northeast community bank" | "necommunitybank.com"

For “Northeast community bancorp northeast community bank necommunitybank.com”, the matching SEC registrant is NorthEast Community Bancorp, Inc./MD/, which trades as NECB and files under Central Index Key 1847398. EDGAR puts it in the “Savings Institutions, Not Federally Chartered” industry code with MD as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-23, across 219 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-13 by NorthEast Community Bancorp, Inc./MD/ (CIK 1847398) — source document:

Northeast Community Bancorp, Inc. (the “Company”) is a Maryland corporation that was incorporated in May 2021 to be the successor to NorthEast Community Bancorp, Inc., a federally chartered corporation (the “Mid-Tier Holding Company”), upon completion of the second-step conversion of NorthEast Community Bank (the “Bank”) from the two-tier mutual holding company structure to the stock holding company structure. NorthEast Community Bancorp, MHC was the former mutual holding company for the Mid-Tier Holding Company prior to the completion of the second-step conversion. In conjunction with the second-step conversion, each of NorthEast Community Bancorp, MHC and the Mid-Tier Holding Company merged out of existence and now cease to exist. The second-step conversion was completed on July 12, 2021, at which time the Company sold, for gross proceeds of $97.8 million, a total of 9,784,077 shares of common stock at $10.00 per share.

Financial trend for NorthEast Community Bancorp, Inc./MD/ from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $72.00 million (2022-12-31) to $154.12 million (2025-12-31), a change of +114.0%; net income (loss) went from $24.84 million (2022-12-31) to $44.41 million (2025-12-31), a change of +78.8%; total assets went from $1.42 billion (2022-12-31) to $2.06 billion (2025-12-31), a change of +44.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1847398, tags Assets, InterestAndDividendIncomeOperating, NetIncomeLoss; 4 periods shown, dashes mark figures NorthEast Community Bancorp, Inc./MD/ did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for NorthEast Community Bancorp, Inc./MD/ (CIK 1847398) lists its business address as 325 HAMILTON AVENUE, WHITE PLAINS, NY, which helps confirm you are on the right company’s site.

Current reports. Of the 46 8-K or 6-K reports in NorthEast Community Bancorp, Inc./MD/’s recent EDGAR index, the 4 listed here run from 2026-04-30 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1847398 is on the EDGAR company page; the latest 10-K there is dated 2026-03-13 and the oldest filing in the recent index dates from 2021-03-08. Insider trades for NorthEast Community Bancorp, Inc./MD/ appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nucana nucana plc nucana.com

Also searched as: "nucana" | "nucana plc" | "nucana.com"

For “Nucana nucana plc nucana.com”, the matching SEC registrant is NuCana plc, which trades as NCNA and files under Central Index Key 1709626. EDGAR puts it in the “Pharmaceutical Preparations” industry code with United Kingdom as its state or country of incorporation; its earlier registered name was NuCana BioMed Ltd. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-09-30, across 282 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-03-19 by NuCana plc (CIK 1709626) — source document:

Financial Information 125 A. Consolidated Statements and Other Financial Information 125 B. Significant Changes 125 Item 9. Additional Information 126 A. Share Capital 126 B. Memorandum and Articles of Association 126 C. Material Contracts 139 D. Exchange Controls 139 E. Taxation 139 F. Dividends and Paying Agents 147 G. Statement by Experts 147 H. Documents on Display 147 I. Subsidiary Information 147 Item 11. Quantitative and Qualitative Disclosures About Market Risk 147 Item 12. Description of Securities Other than Equity Securities 148 A. Debt Securities 148 B. Warrants and Rights 148 C. Other Securities 148 D. American Depositary Shares 148 PART II 151 Item 13. Defaults, Dividend Arrearages and Delinquencies 151 Item 14.

Financial trend for NuCana plc from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -32,021,000 GBP (2022-12-31) to -29,353,000 GBP (2025-12-31), a change of +8.3%; total assets went from 58,254,000 GBP (2022-12-31) to 29,834,000 GBP (2025-12-31), a change of -48.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1709626, tags Assets, ProfitLoss; 4 periods shown, dashes mark figures NuCana plc did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for NuCana plc (CIK 1709626) lists its business address as 3 LOCHSIDE WAY, EDINBURGH, United Kingdom, which helps confirm you are on the right company’s site.

Current reports. Of the 137 8-K or 6-K reports in NuCana plc’s recent EDGAR index, the 4 listed here run from 2026-06-01 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1709626 is on the EDGAR company page; the latest 20-F there is dated 2026-03-19 and the oldest filing in the recent index dates from 2017-06-26. Insider trades for NuCana plc appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Old republic international oldrepublic.com

Also searched as: "old republic international" | "oldrepublic.com"

For “Old republic international oldrepublic.com”, the matching SEC registrant is OLD REPUBLIC INTERNATIONAL CORP, which trades as ORI and files under Central Index Key 74260. EDGAR puts it in the “Surety Insurance” industry code with DE as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-22, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-02-26 by OLD REPUBLIC INTERNATIONAL CORP (CIK 74260) — source document:

Old Republic International Corporation is a Chicago-based holding company engaged in the business of insurance underwriting and related services. It conducts its business through a number of operating companies, which utilize one or more insurance company subsidiaries to issue their policies, and is organized into two segments: Specialty Insurance and Title Insurance. References herein to such segments apply to the Company's subsidiaries engaged in these respective segments of business. The results of the Republic Financial Indemnity Group (RFIG) Run-off business, previously a reportable segment, are deemed immaterial and reflected within the Corporate & Other caption of this report through the effective date of its sale of May 31, 2024, along with the results of a small life and accident insurance business.

Financial trend for OLD REPUBLIC INTERNATIONAL CORP from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $8.08 billion (2022-12-31) to $9.14 billion (2025-12-31), a change of +13.0%; net income (loss) went from $686.40 million (2022-12-31) to $935.40 million (2025-12-31), a change of +36.3%; total assets went from $25.16 billion (2022-12-31) to $29.86 billion (2025-12-31), a change of +18.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 74260, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures OLD REPUBLIC INTERNATIONAL CORP did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for OLD REPUBLIC INTERNATIONAL CORP (CIK 74260) lists its business address as 307 N MICHIGAN AVE, CHICAGO, IL, which helps confirm you are on the right company’s site.

Current reports. Of the 153 8-K or 6-K reports in OLD REPUBLIC INTERNATIONAL CORP’s recent EDGAR index, the 4 listed here run from 2026-05-27 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 74260 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2011-02-03. Insider trades for OLD REPUBLIC INTERNATIONAL CORP appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Olenox industries olenox industries inc. safeandgreenholdings.com

Also searched as: "olenox industries" | "olenox industries inc." | "safeandgreenholdings.com"

For “Olenox industries olenox industries inc. safeandgreenholdings.com”, the matching SEC registrant is OLENOX INDUSTRIES INC., which trades as OLOX and files under Central Index Key 1023994. EDGAR puts it in the “Wholesale-Lumber & Other Construction Materials” industry code with DE as its state or country of incorporation; its earlier registered name was SAFE & GREEN HOLDINGS CORP.. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-21, across 929 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-06-30 by OLENOX INDUSTRIES INC. (CIK 1023994) — source document:

We operate in the following four segments: (i) manufacturing for construction; (ii) technology; (iii) oil and gas; and (iv) environmental services. The construction segment designs and constructs modular structures in our factory using recycled shipping containers; in the past, traditional wood and steel frames were also used. In the technology sector, we offer turnkey solutions to monitor oil and gas operations remotely and other similar applications. Our oil and gas wells operate in multiple states and in Canada. The environmental services segment operates in the oil and gas industry and provides renewable energy and other services on-site. We are a provider of modular structures (“Modules”). We currently provide Modules made out of code-engineered cargo shipping containers as both permanent or temporary structures for use as residential housing, commercial structures and industrial applications.

Financial trend for OLENOX INDUSTRIES INC. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $24.39 million (2022-12-31) to $2.95 million (2025-12-31), a change of -87.9%; net income (loss) went from -$8.32 million (2022-12-31) to -$18.82 million (2025-12-31), a change of -126.2%; total assets went from $26.56 million (2022-12-31) to $36.04 million (2025-12-31), a change of +35.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1023994, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures OLENOX INDUSTRIES INC. did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for OLENOX INDUSTRIES INC. (CIK 1023994) lists its business address as 1207 N FM 3083 RD E, CONROE, TX, which helps confirm you are on the right company’s site.

Current reports. Of the 278 8-K or 6-K reports in OLENOX INDUSTRIES INC.’s recent EDGAR index, the 4 listed here run from 2026-08-06 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1023994 is on the EDGAR company page; the latest 10-K there is dated 2026-06-30 and the oldest filing in the recent index dates from 1997-02-11. Insider trades for OLENOX INDUSTRIES INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Oncolytics biotech oncolytics biotech inc oncolyticsbiotech.com

Also searched as: "oncolytics biotech" | "oncolytics biotech inc" | "oncolyticsbiotech.com"

For “Oncolytics biotech oncolytics biotech inc oncolyticsbiotech.com”, the matching SEC registrant is ONCOLYTICS BIOTECH INC, which trades as ONCY and files under Central Index Key 1129928. EDGAR puts it in the “Pharmaceutical Preparations” industry code with NV as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 8-K filed 2026-10-20, across 1000 filings on record. This is reference material, not trading advice.

Business description, quoted from the 10-K filed 2026-03-30 by ONCOLYTICS BIOTECH INC (CIK 1129928) — source document:

Pelareorep induces a new army of tumor-reactive T cells, helps these cells to infiltrate the tumor through an inflammatory process, and upregulates the expression of PD-1/PD-L1. By priming the immune system with pelareorep, we believe we can increase the proportion of patients who respond to various cancer treatments, including immunotherapies, especially in cancers where existing treatment regimens have failed or provided limited benefit. Going Concern We have not been profitable since our inception and expect to continue to incur substantial losses as we continue research and development efforts. We do not expect to generate significant revenues until and unless pelareorep becomes commercially viable. We expect our current cash resources to be able to fund near-term milestones, but they are not sufficient to fund our planned operations over the next 12 months from the date of issuance of our consolidated financial statements included in this Annual Report.

Financial trend for ONCOLYTICS BIOTECH INC from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) went from -$22.79 million (2024-12-31) to -$28.76 million (2025-12-31), a change of -26.2%; total assets went from $13.42 million (2024-12-31) to $7.58 million (2025-12-31), a change of -43.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1129928, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures ONCOLYTICS BIOTECH INC did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for ONCOLYTICS BIOTECH INC (CIK 1129928) lists its business address as SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA, which helps confirm you are on the right company’s site.

Current reports. Of the 795 8-K or 6-K reports in ONCOLYTICS BIOTECH INC’s recent EDGAR index, the 4 listed here run from 2026-09-29 to 2026-10-20, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1129928 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2008-01-23. Insider trades for ONCOLYTICS BIOTECH INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Onfolio onfolio holdings onfolio.com onfolio holdings inc.

Also searched as: "onfolio" | "onfolio holdings" | "onfolio.com" | "onfolio holdings inc."

For “Onfolio onfolio holdings onfolio.com onfolio holdings inc.”, the matching SEC registrant is Onfolio Holdings, Inc, which trades as ONFO, ONFOP, ONFOW and files under Central Index Key 1825452. EDGAR puts it in the “Services-Computer Processing & Data Preparation” industry code with DE as its state or country of incorporation; its earlier registered name was Onfolio Holdings Inc. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a S-1 filed 2026-10-23, across 198 filings on record. This is reference material, not trading advice.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for Onfolio Holdings, Inc (CIK 1825452) lists its business address as 1007 NORTH ORANGE STREET 4TH FLOOR, WILMINGTON, DE, which helps confirm you are on the right company’s site.

Updated Oct 25, 2026 ET

Powell max powell max limited

Also searched as: "powell max" | "powell max limited"

For “Powell max powell max limited”, the matching SEC registrant is Powell Max Ltd, which trades as PMAX and files under Central Index Key 2012096. EDGAR puts it in the “Services-Miscellaneous Business Services” industry code with Virgin Islands, British as its state or country of incorporation. Data below comes straight from EDGAR as checked on Oct 25, 2026, where the latest item is a 6-K filed 2026-10-02, across 66 filings on record. This is reference material, not trading advice.

Business description, quoted from the 20-F filed 2026-04-30 by Powell Max Ltd (CIK 2012096) — source document:

We commenced operations in February 2019 with the establishment of JAN Financial Press Limited, or JAN Financial, a company incorporated under the laws of Hong Kong on February 27, 2019, which is wholly owned by Powell Max. Powell Max Limited, our ultimate holding company, was incorporated under the laws of the British Virgin Islands, or the BVI, on January 8, 2019 as a BVI business company with limited liability. Initially, Powell Max had 50,000 ordinary shares issued and allotted to Ms. Po Man Stella Leung. On January 19, 2024, as part of the reorganization undertaken in contemplation of our initial public offering, or IPO, Ms. Leung entered into a share swap arrangement with Bliss On Limited, a company incorporated under the laws of the BVI and wholly owned by Ms.

Financial trend for Powell Max Ltd from annual reports, periods 2022-12-31 to 2024-12-31: revenue went from 37,772,821 HKD (2022-12-31) to 36,461,260 HKD (2024-12-31), a change of -3.5%; net income (loss) went from -98,603 HKD (2022-12-31) to -18,074,094 HKD (2024-12-31), a change of -18230.2%; total assets went from 22,989,475 HKD (2023-12-31) to 62,571,860 HKD (2024-12-31), a change of +172.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2012096, tags Assets, ProfitLoss, Revenue; 3 periods shown, dashes mark figures Powell Max Ltd did not tag for that period.

Powell Max Ltd has 66 filings in its recent EDGAR index, including 2 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-10-02.

Current reports. Of the 26 8-K or 6-K reports in Powell Max Ltd’s recent EDGAR index, the 4 listed here run from 2026-03-23 to 2026-10-02, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2012096 is on the EDGAR company page; the latest 20-F there is dated 2026-04-30 and the oldest filing in the recent index dates from 2024-03-19. Insider trades for Powell Max Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET